COG7

Chr 16AR

component of oligomeric golgi complex 7

Required for normal Golgi function

Primary Disease Associations & Inheritance

Congenital disorder of glycosylation, type IIeMIM #608779
AR
388
ClinVar variants
25
Pathogenic / LP
0.00
pLI score
0
Active trials
Clinical SummaryCOG7
🧬
Gene-Disease Validity (ClinGen)
COG7-congenital disorder of glycosylation · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
25 Pathogenic / Likely Pathogenic· 156 VUS of 388 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
0.66LOEUF
pLI 0.000
Z-score 3.26
OE 0.45 (0.310.66)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
0.76Z-score
OE missense 0.90 (0.820.98)
382 obs / 426.0 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.45 (0.310.66)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.90 (0.820.98)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.0.96
01.21.6
LoF obs/exp: 18 / 40.4Missense obs/exp: 382 / 426.0Syn Z: 0.38

ClinVar Variant Classifications

388 submitted variants in ClinVar

Classification Summary

Pathogenic17
Likely Pathogenic8
VUS156
Likely Benign201
Benign3
Conflicting3
17
Pathogenic
8
Likely Pathogenic
156
VUS
201
Likely Benign
3
Benign
3
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
3
0
14
0
17
Likely Pathogenic
5
1
2
0
8
VUS
1
147
8
0
156
Likely Benign
0
2
92
107
201
Benign
0
0
3
0
3
Conflicting
3
Total9150119107388

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

COG7 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

COG7-related congenital disorder of glycosylation

definitive
ARLoss Of FunctionAbsent Gene Product
Dev. Disorders
G2P ↗

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

Congenital disorder of glycosylation, type IIe

MIM #608779

Molecular basis of disorder known

Autosomal recessive
📖
GeneReview available — COG7
Authoritative clinical overview · NCBI Bookshelf · Recommended first read
Open GeneReview ↗
Clinical Literature
Landmark / reviewRecent case evidence
Key Publications
Landmark & review papers · by relevance
PubMed
Metabolic cutis laxa syndromes.
Mohamed M et al.·J Inherit Metab Dis
2011Review
A new mutation in COG7 extends the spectrum of COG subunit deficiencies.
Zeevaert R et al.·Eur J Med Genet
2009Case report
Top 10 resultsSearch PubMed ↗

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →